Nexalis Therapeutics Limited (ASX:NX1)
Australia · Delayed Price · Currency is AUD 0.0090
-0.0010 (-10.00%)
At close: Sep 18, 2026
Nexalis Therapeutics Market Cap
Nexalis Therapeutics has a market cap or net worth of 2.53 million as of September 17, 2026. Its market cap has decreased by -67.07% in one year.
Market Cap
2.53M
Enterprise Value
2.46M
Revenue
1.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since January 11, 2017, Nexalis Therapeutics's market cap has decreased from 29.98M to 2.53M, a decrease of -91.56%. That is a compound annual growth rate of -22.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 2.53M | -55.95% |
| Dec 29, 2025 | 5.74M | -23.11% |
| Dec 30, 2024 | 7.47M | 35.76% |
| Dec 18, 2023 | 5.50M | -51.02% |
| Dec 29, 2022 | 11.24M | -25.89% |
| Dec 30, 2021 | 15.16M | 46.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ReNerve | 12.23M |
| AdAlta | 9.64M |
| Invex Therapeutics | 8.64M |
| Bio-Gene Technology | 7.45M |
| Vectus Biosystems | 7.40M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Biotron | 5.57M |